- Home
- CWBC vs HQL Comparison
CWBC vs HQL Comparison
Compare CWBC & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CWBC | HQL |
|---|---|---|
| Founded | 1989 | 1992 |
| Country | United States | United States |
| Employees | 338 | N/A |
| Industry | Major Banks | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.9M | 492.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CWBC | HQL |
|---|---|---|
| Price | $22.85 | $15.87 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 162.1K | 128.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 2.07% | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $39.39 | N/A |
| Revenue Next Year | $17.64 | N/A |
| P/E Ratio | ★ $12.13 | $20.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.57 | $10.55 |
| 52 Week High | $25.72 | $17.80 |
Technical Indicators
Market Signals| Indicator | CWBC | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 32.38 |
| Support Level | $22.03 | $15.67 |
| Resistance Level | $24.47 | $17.51 |
| Average True Range (ATR) | 0.66 | 0.29 |
| MACD | -0.17 | -0.12 |
| Stochastic Oscillator | 15.25 | 10.42 |
Price Performance
Historical ComparisonAbout CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.